Biogen Inc. buy matumba
Start price
07.12.11
/
50%
€83.50
Target price
10.05.12
€102.75
Performance (%)
23.28%
End price
10.05.12
€102.94
Summary
This prediction ended on 10.05.12 with a price of €102.94. The prediction had a final performance of 23.28%. matumba has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m | 1y | 3y |
|---|---|---|---|---|
| Biogen Inc. | -1.244% | -1.244% | 58.750% | -27.310% |
| iShares Core DAX® | 0.855% | 0.389% | 2.533% | 52.003% |
| iShares Nasdaq 100 | -0.989% | -4.400% | 25.154% | 77.536% |
| iShares Nikkei 225® | -1.781% | -11.216% | 44.398% | 64.676% |
| iShares S&P 500 | 0.057% | 0.778% | 20.953% | 63.009% |
Comments by matumba for this prediction
In the thread Biogen Inc. diskutieren
38% Gewinnsteigerung
38% Gewinnsteigerung im 3. Quartal, der älteste Biotechunternehmer läßt die Mitbewerber alt aussehen.